Semaglutide is not a suitable treatment for anyone with the following: Medullary thyroid cancer Multiple endocrine neoplasias People with type 1 diabetes Those with type 2 diabetes already taking GLP-1 medication Pancreatitis Kidney disease Women who are pregnant or breastfeeding Do I need to follow a special diet while taking semaglutide
An infection manifests as fever, redness, swelling, warmth, and discomfort at the injection site
If you are considering a GLP-1 medication, the safest next step is a clinician conversation that covers eligibility, dosing, side effect management, and interactions, plus how to monitor results over time
7 Approximately 3.3 million Canadians have type 1 or type 2 diabetes and this number is expected to rise to 4.8 million by 2024
Unfortunately treatment of complex chronic diseases such as obesity has often proven recalcitrant to attempts to attain the desired health benefits [69]